Treatment of stingray injury with topical becaplermin gel

Journal of the American Podiatric Medical Association

Volumn 89, Issue 10, 1999, Pages 531-533

  Baldinger, Philip J ^a,b  

^a American College of Foot and Ankle Surgeons   (United States)

^b Cortez Podiatry Associates ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CASE REPORT; FISH; FOOT INJURY; FOOT ULCER; FOREIGN BODY; GEL; HUMAN; MALE; MIDDLE AGED;

ANIMALS; FISHES; FOOT INJURIES; FOOT ULCER; FOREIGN BODIES; GELS; HUMANS; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; RECOMBINANT PROTEINS;

EID: 0033212090     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-89-10-531     Document Type: Article

References (12)

1. RODRIGUES RJ: Pharmacology of South American freshwater stingray venom (Polamotrygon moloro). Trans N Y Acad Sci 34: 677, 1972.
2. HALSTEAD BW: Current status of marine biotoxicology: an overview. Clin Toxicol 18: 1, 1981.
3. EVANS RJ, DAVIES RS: Stingray injury. J Accid Emerg Med 13: 224, 1996.
4. HO P-L, TANG W-M, LO K-S, ET AL: Necrotizing fasciitis due to Vibrio alginolyticus following an injury inflicted by a stingray. Scand J Infect Dis 30: 192, 1998.
5. BURK MP, RICHTER PA: Stingray injuries of the foot: two case reports. JAPMA 80: 260, 1990.
6. AGNEW PS, BORDEN EL: Pedal envenomation by a stingray: a case report. JAPMA. 77: 559, 1987.
7. KIRITSY CP, LYNCH AB, LYNCH SE: Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med 4: 729, 1993.
8. BENNETT NT, SCHULTZ GS: Growth factors and wound healing: part II. role in normal and chronic wound healing. Am J Surg 166: 74, 1993.
9. LAWRENCE WT, DIEGELMANN RF: "Cytokines and Antagonists in Wound Healing," in Cytokines in Trauma and Hemorrhage, ed by HJ Sugerman, EJ DeMaria, p 81, RG Landes, Austin, TX, 1997.
10. WIEMAN TJ, SMIELL JM, SU Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 21: 822, 1998.
11. D'HEMECOURT PA, SMIELL JM, KARIM MR: Sodium carboxymethylcellulose aqueous-based gel vs. becaplermin gel in patients with nonhealing lower extremity diabetic ulcers. Wounds 10: 69, 1998.
12. STEED DL, DIABETIC ULCER STUDY GROUP: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 21: 71, 1995.